TP53 and metabolic dysfunction-associated steatotic liver disease: The expression of the pro-apoptotic protein p53 is increased while anti-apoptotic protein Bcl-2 is inhibited with the enhancement of the inflammatory response in non-alcoholic fatty liver disease (NAFLD) patients (Panasiuk et al., 2006).